News & Updates

Central obesity raises risk of arterial stiffness even in people with normal weight

03 Mar 2024

Central obesity in people with normal weight appears to contribute to a heightened risk of arterial stiffness in the presence of hypertension, according to a study from China.

Central obesity raises risk of arterial stiffness even in people with normal weight

03 Mar 2024

Diabetic retinopathy predicts heart problems in type 1 diabetes

28 Feb 2024

Among individuals with type 1 diabetes, diabetic retinopathy is independently associated with prevalent and incident cardiovascular disease, as reported in a study.

Diabetic retinopathy predicts heart problems in type 1 diabetes

28 Feb 2024

Low sexual function scores tied to arterial stiffness in postmenopausal women

27 Feb 2024

Lower scores of sexual function in postmenopausal women are predictive of weakened vascular function, as manifested by arterial stiffening, which then contributes to systolic blood pressure (SBP) changes, according to a recent study.

Low sexual function scores tied to arterial stiffness in postmenopausal women

27 Feb 2024

Quitting smoking in pregnancy tied to weight gain and high HDP risk, but lower stillbirth risk

26 Feb 2024

Smoking discontinuation during pregnancy is associated with both positive and negative outcomes, such as reduced risk of stillbirth but higher risk of hypertensive disorders of pregnancy (HDP) and weight gain, according to a study.

Quitting smoking in pregnancy tied to weight gain and high HDP risk, but lower stillbirth risk

26 Feb 2024

Pitavastatin reduces noncalcified plaque in people with HIV at low-to-moderate CVD risk

25 Feb 2024

In people living with HIV (PWH) who are at low-to-moderate risk of cardiovascular disease (CVD), use of pitavastatin for 2 years leads to a reduction in noncalcified plaque volume and progression, which potentially contributes to a decrease in major adverse cardiovascular events (MACE), according to the results of the mechanistic substudy of the REPRIEVE trial.

Pitavastatin reduces noncalcified plaque in people with HIV at low-to-moderate CVD risk

25 Feb 2024

Apixaban recommended for blood clot prevention in gynaecologic cancer surgery

25 Feb 2024

Prophylactic apixaban appears to effectively reduce the risk of venous thromboembolism (VTE) for patients undergoing open surgery for gynaecologic malignancies and should be considered the standard of care for VTE prophylaxis in this population, according to a retrospective study.

Apixaban recommended for blood clot prevention in gynaecologic cancer surgery

25 Feb 2024

Severe OSA in IHD patients ups AF risk during sleep

24 Feb 2024 by

Severe obstructive sleep apnoea (OSA) in patients with ischaemic heart disease (IHD) is associated with an increased risk of atrial fibrillation (AF) during sleep, according to a Singapore study.

Severe OSA in IHD patients ups AF risk during sleep

24 Feb 2024

RNA interference with zilebesiran shows therapeutic potential in mild-to-moderate hypertension

22 Feb 2024

Zilebesiran, an investigational RNA interference therapeutic agent that targets hepatic angiotensinogen synthesis, appears to have a promising blood pressure (BP)-lowering effect in adults with mild-to-moderate hypertension, according to the phase II KARDIA-1 trial.

RNA interference with zilebesiran shows therapeutic potential in mild-to-moderate hypertension

22 Feb 2024

SG Framingham Risk Score needs recalibration to improve prediction accuracy

21 Feb 2024 by

Current guidelines that are being used in Singapore (SG) for predicting cardiovascular disease (CVD) must be updated to improve risk prediction accuracy. This can be done by recalibrating risk functions and employing wearable metrics that provide a huge amount of objective health data, suggests a study.

SG Framingham Risk Score needs recalibration to improve prediction accuracy

21 Feb 2024

Pharmacy model improves drug access, care transition in HF

20 Feb 2024

Implementing a pharmacy practice model consisting of an integrated four-member team (three pharmacists and one specialty technician) leads to better medication access and improved education among heart failure (HF) patients, reports a study. The model also allows for transition of care (ToC) at multiple points in the care process, resulting in enhanced medication safety.

Pharmacy model improves drug access, care transition in HF

20 Feb 2024

News & Updates

Filter by Specialty:

Specialty:

Central obesity raises risk of arterial stiffness even in people with normal weight

Central obesity raises risk of arterial stiffness even in people with normal weight

Diabetic retinopathy predicts heart problems in type 1 diabetes

Diabetic retinopathy predicts heart problems in type 1 diabetes

Low sexual function scores tied to arterial stiffness in postmenopausal women

Low sexual function scores tied to arterial stiffness in postmenopausal women

Quitting smoking in pregnancy tied to weight gain and high HDP risk, but lower stillbirth risk

Quitting smoking in pregnancy tied to weight gain and high HDP risk, but lower stillbirth risk

Pitavastatin reduces noncalcified plaque in people with HIV at low-to-moderate CVD risk

Pitavastatin reduces noncalcified plaque in people with HIV at low-to-moderate CVD risk

Apixaban recommended for blood clot prevention in gynaecologic cancer surgery

Apixaban recommended for blood clot prevention in gynaecologic cancer surgery

Severe OSA in IHD patients ups AF risk during sleep

Severe OSA in IHD patients ups AF risk during sleep

RNA interference with zilebesiran shows therapeutic potential in mild-to-moderate hypertension

RNA interference with zilebesiran shows therapeutic potential in mild-to-moderate hypertension

SG Framingham Risk Score needs recalibration to improve prediction accuracy

SG Framingham Risk Score needs recalibration to improve prediction accuracy

Pharmacy model improves drug access, care transition in HF

Pharmacy model improves drug access, care transition in HF